crystallization communications
Purification, crystallization and preliminary X-ray analysis of a deletion mutant of a major buckwheat allergen
aDepartment of Structural Biology, School of Pharmacy, Iwate Medical University, Yahaba, Iwate 028-3694, Japan, bDepartment of BioEngineering, Nagaoka University of Technology, Nagaoka, Niigata 940-2188, Japan, and cDivision of Novel Foods and Immunochemistry, National Institute of Health Sciences (NIHS), Setagaya, Tokyo 158-8501, Japan
*Correspondence e-mail: tnonaka@iwate-med.ac.jp
A 16 kDa buckwheat protein (BWp16) is a major allergen responsible for immediate hypersensitivity reactions including anaphylaxis. A deletion mutant of BWp16 (rBWp16ΔN) was overproduced and purified and was shown to be immunologically active. A three-wavelength MAD data set was collected from a crystal of selenomethionine-labelled rBWp16ΔN. The crystal belonged to the triclinic P1, with unit-cell parameters a = 28.39, b = 31.54, c = 32.20 Å, α = 111.92, β = 108.91, γ = 98.74°. One monomer was expected to be present in the based on the calculated Matthews coefficient of 1.76 Å3 Da−1.
Keywords: buckwheat allergen; 2S albumin; BWp16.
1. Introduction
Buckwheat (Fagopyrum esculentum) belongs to the Polygonaceae family. Buckwheat noodles are a popular food in East Asian countries. Buckwheat-flour products are also becoming popular in Western countries as a healthy food with a high protein content. However, some people exhibit hypersensitivity mediated by an antibody IgE specific to buckwheat proteins (Wieslander, 1996; Horesh, 1972). Ingestion of a small amount of buckwheat can cause immediate hypersensitivity reactions, termed anaphylaxis. This hypersensitivity often starts in childhood and continues throughout life, in contrast to allergies to other foods such as cow's milk (Takahashi et al., 1998).
Investigators have reported that 24, 19, 16, 14, 10 and 9 kDa buckwheat proteins can react with IgE antibodies from allergic patients (Nagata et al., 2000; Park et al., 2000; Tanaka et al., 2002; Yoshimasu et al., 2000; Matsumoto et al., 2004). Most of these investigations were performed using nonheated and non-pepsin-digested buckwheat extracts. However, the foods that we consume are usually cooked and are digested by proteolytic enzymes such as pepsin in our bodies. Tanaka and coworkers demonstrated that the 16 kDa buckwheat protein BWp16, a member of the 2S albumin family (Shewry et al., 1995), was resistant to pepsin and preserved its reactivity with IgE antibodies from allergic patients with immediate hypersensitivity reactions (Tanaka et al., 2002). In contrast, the other candidates were digested by pepsin and the resulting fragments lost their reactivity with IgE antibodies. Thus, BWp16 is a strong candidate as the major buckwheat allergen responsible for immediate hypersensitivity reactions including anaphylaxis.
The epitopes recognized by IgE antibodies are divided into two types: a linear ΔN), which appears to be immunologically equivalent to BWp16. Here, we describe the purification, crystallization and preliminary X-ray analysis of rBWp16ΔN.
in which the key residues arise from a linear amino-acid sequence and a structural in which the key residues arise from widely different positions in the linear amino-acid sequence. As mentioned above, IgE antibodies might recognize the structural epitopes of BWp16 because of its pepsin resistance. To investigate the molecular mechanism of buckwheat allergy at an atomic level, it is important to determine the structural epitopes of the major buckwheat allergen BWp16. Therefore, we attempted the structural characterization of recombinant BWp16 (rBWp16) and its N-terminal deletion mutant (rBWp162. Materials and methods
2.1. Cloning, expression and purification
rBWp16 was prepared as described previously (Koyano et al., 2006) and further purified using a prepacked anion-exchange column with a bed volume of 1 ml (HiTrap Q FF, GE Healthcare). rBWp16ΔN was overproduced in Escherichia coli as a soluble protein with a glutathione S-transferase (GST) tag at its N-terminus. The gene encoding residues 13–127 was amplified using the forward primer 5′-CGTGGATCCCTGGTTCCGCGTGGAAGCTCAAAGTGCATGCGA-3′ and the reverse primer 5′-CGGCTCGAGTTACACAAAATACCGATTTCCTCT-3′. [The underlined sequences denote introduced BamHI and XhoI sites, respectively, and the italicized sequence denotes a thrombin The codon AGC (shown in bold in the forward primer) for the last amino acid (Ser) of the thrombin overlapped with that for the 13th amino acid of BWp16 (Ser13).] The resulting fragment was cut and cloned into pGEX-6P-2 (GE Healthcare) vector. rBWp16ΔN consisted of residues 13–127 of BWp16 and the N-terminal vector-derived Gly residue left after removal of the GST tag by thrombin cleavage. The constructed plasmid was then transformed into E. coli strain Origami B (DE3) (Novagen). The cells were grown at 310 K in Luria–Bertani (LB) medium. When the of the medium reached 0.4 at 600 nm, isopropyl β-D-1-thiogalactopyranoside was added to a final concentration of 0.4 mM. Cultivation was continued for 4 h at 298 K. The cells were resuspended in phosphate-buffered saline (PBS) and then sonicated. The soluble fraction was passed through a 0.22 µm syringe filter and then bound to 5 ml of Glutathione-Sepharose FF (GE Healthcare) in an open column. The bound protein was exhaustively washed with PBS and eluted with 50 mM Tris–HCl pH 8.0 containing 10 mM reduced γ-glutathione. The GST-fusion protein was digested by thrombin and dialyzed against PBS at 293 K. To remove the digested GST tag, the digested protein was again applied onto the above-mentioned open column. The flowthrough fraction was dialyzed against 20 mM Tris–HCl pH 8.5 and loaded onto MonoQ HR10/10 (GE Healthcare) equilibrated with the same buffer. The bound rBWp16ΔN was eluted with a linear gradient (20 mM increase per column volume) of sodium chloride (NaCl) at a flow rate of 2.0 ml min−1. Selenomethionine (SeMet)-labelled protein was overproduced in E. coli strain B834 (DE3) (Novagen). It was prepared by the same procedure as described above except for the use of LeMaster medium (LeMaster & Richards, 1985) instead of LB medium.
2.2. Enzyme-linked immunosorbent assay (ELISA)
After coating 96-well plates (Nunc LockWell Module Plate, Nunc) with rBWp16 or rBWp16ΔN (1.0 µg per 50 µl of 50 mM sodium carbonate buffer pH 9.6 in the well) and incubating overnight at 277 K, they were washed with PBS containing 0.05% Tween 20 (PBS-T) and blocked with 0.1% casein-PBS for 1 h at room temperature. These plates were then washed again with PBS-T and incubated overnight at 277 K with serum samples diluted to 5% (1:20 dilution) in 0.1% casein-PBS. The wells were washed four times with PBS-T containing 1.0 M NaCl. They were then exposed to horseradish peroxidase (HRP) conjugated goat anti-human IgE antibodies (Nordic Immunology, 1:1000 dilution) in 0.1% casein-PBS for 1 h at room temperature. The bound antibodies were reacted with a substrate solution (TMB reagent, BD Biosciences). The colorimetric intensity at 450 nm was measured according to the manufacturer's protocol.
2.3. Crystallization
Initial screening for crystallization was performed by the hanging-drop vapour-diffusion method at 293 K. The protein solution was adjusted to 15 mg ml−1 (1.1 mM) in 10 mM MES pH 6.5 containing 10 mM NaCl. Each hanging drop was prepared by mixing 0.7 µl each of the protein solution and the reservoir solution and was equilibrated against 0.5 ml of the latter. Commercially available kits manufactured by Emerald BioSystems and Hampton Research were used for initial crystallization screening and a total of approximately 400 conditions were tried. The identified conditions were then optimized by replacing the buffer and/or the precipitant and by changing the concentrations of the precipitant, buffer and additive.
2.4. Data collection and processing
Crystals were mounted in cryoloops (Hampton Research) and cryoprotected by soaking them briefly in mother liquor containing 20%(w/v) 2-methyl-2,4-pentanediol before flash-freezing in a stream of nitrogen gas at 95 K. Native and three-wavelength MAD data sets were collected on beamline BL6A at the Photon Factory using a Quantum 4R detector (Area Detector Systems Corporation). The MAD experiment wavelengths were determined from an experiment on an SeMet-labelled rBWp16ΔN crystal. The diffraction data were indexed, integrated and scaled using MOSFLM (Powell, 1999) and SCALA (Collaborative Computational Project, Number 4, 1994) as implemented in XIA2 (https://www.ccp4.ac.uk/xia/ ). An anomalous for the peak data set (λ = 0.9786 Å) was calculated using FFT (Read & Schierbeek, 1988) and contoured sections were drawn using MAPSLICER (Winn et al., 2002).
3. Results and discussion
A homology search of BWp16 within the Protein Data Bank showed that BWp16 had sequence similarity to 2S albumins or related proteins from peanut (PDB code 1w2q ; 30% identity; Lehmann et al., 2006), castor bean (PDB code 1psy ; 27% identity; Pantoja-Uceda et al., 2003) and oilseed rape (PDB code 1sm7 ; 23% identity; Pantoja-Uceda et al., 2004). These structures were determined by NMR spectroscopy; no crystal structures of 2S albumins were available. The N-terminal regions of the 2S albumins from peanut and castor bean were highly disordered. We therefore prepared an N-terminal deletion mutant BWp16ΔN as the N-terminal region of BWp16 was predicted to be flexible by analogy with the 2S albumins. rBWp16ΔN was expressed as a GST-fusion protein in E. coli and was purified to apparent yielding approximately 1.5 mg of protein per litre of medium.
To clarify whether rBWp16ΔN could react with IgE antibodies from an allergic patient, we performed ELISA. The IgE-binding activity of serum from a buckwheat-allergic patient to rBWp16ΔN was comparable with that to rBWp16. The colorimetric intensities measured at 450 nm were 0.168 ± 0.024 and 0.161 ± 0.028 for rBWp16 and rBWp16ΔN, respectively. rBWp16 was shown to be immunologically equivalent to the wild-type BWp16 (Koyano et al., 2006). These results indicate that rBWp16ΔN possesses allergenicity and that the 12 N-terminal residues are not necessary for IgE binding.
After trials of approximately 400 conditions in the initial screening, an rBWp16ΔN crystal was obtained under condition No. 40 of the Cryo I kit from Emerald BioSystems [40%(v/v) ethanol, 100 mM phosphate–citrate pH 4.2, 5%(w/v) PEG 1000]. However, we did not succeed in crystallizing rBWp16. Therefore, the deletion of the 12 N-terminal residues was likely to affect crystallization. Crystallization conditions were optimized for rBWp16ΔN and the following two promising conditions were established. One is a slight modification of Cryo I condition No. 40 [36%(v/v) ethanol, 0.1 M phosphate–citrate pH 4.2, 1%(w/v) PEG 1000; condition I]. The other was 29%(v/v) 1-propanol, 0.1 M phosphate–citrate pH 4.2, 1%(w/v) PEG 1000 (condition II). Plate-like crystals grew within 2 d and reached a maximum dimension of 0.2 mm (Fig. 1a); dissolution occurred within several days under both conditions. A complete data set was collected to 1.72 Å resolution from a native crystal obtained under condition I. Table 1 gives a summary of the data-collection and data-processing statistics. The native crystal belonged to the monoclinic P21, with unit-cell parameters a = 27.92, b = 58.54, c = 32.16 Å, β = 109.34°. The calculated Matthews coefficient of 1.87 Å3 Da−1 (Matthews, 1968), corresponding to a solvent content of 34%, indicated the presence of one monomer in the asymmetric unit.
|
We first attempted to solve the structure of rBWp16ΔN using molecular-replacement (MR) techniques. Three homology models were constructed based on the above-mentioned protein structures using MODELLER (Sali & Blundell, 1993) and were used as search models. However, no significant peaks were found in the rotation and translation functions despite exhaustive attempts and the calculated phases from the MR solutions did not give any interpretable electron density. Therefore, we prepared SeMet-labelled rBWp16ΔN and crystallized it for MAD The purified protein yield decreased to 0.1 mg per litre of medium for derivatization. SeMet-labelled rBWp16ΔN crystals were grown under conditions I and II. Fig. 1(b) shows SeMet-labelled rBWp16ΔN crystals obtained under condition II. In the experiment a clear selenium was monitored from a crystal, enabling us to determine the peak (0.9786 Å), edge (0.9791 Å) and remote (0.9639 Å) wavelengths. A three-wavelength MAD data set was collected to 1.60 Å resolution from a crystal obtained under condition II. The crystal belonged to the triclinic P1, with unit-cell parameters a = 28.39, b = 31.54, c = 32.20 Å, α = 111.92, β = 108.91, γ = 98.74°. One monomer was expected to be present in the based on the calculated Matthews coefficient of 1.76 Å3 Da−1 (Matthews, 1968), corresponding to a solvent content of 30%. Table 1 shows a summary of the data-collection and data-processing statistics. The peak data set showed strong peaks derived from Se atoms in an anomalous contoured at 3.0σ above the mean density level. A section of the map containing the highest peak is shown in Fig. 2. Phasing calculations using SOLVE (Terwilliger & Berendzen, 1999) are now in progress.
Acknowledgements
Synchrotron-radiation experiments were performed at the Photon Factory with the approval of the Photon Factory Advisory Committee, the National Laboratory for High Energy Accelerator Research Organization, Japan (Proposal No. 2007G617) and at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (Proposal No. 2008A1221).
References
Collaborative Computational Project, Number 4 (1994). Acta Cryst. D50, 760–763. CrossRef IUCr Journals Google Scholar
Horesh, A. J. (1972). Ann. Allergy, 30, 685–689. CAS PubMed Web of Science Google Scholar
Koyano, S., Takagi, K., Teshima, R. & Sawada, J. (2006). Int. Arch. Allergy Immunol. 140, 73–81. Web of Science CrossRef PubMed CAS Google Scholar
Lehmann, K., Schweimer, K., Reese, G., Randow, S., Suhr, M., Becker, W. M., Vieths, S. & Rösch, P. (2006). Biochem. J. 395, 463–472. Web of Science PubMed CAS Google Scholar
LeMaster, D. M. & Richards, F. M. (1985). Biochemistry, 24, 7263–7268. CrossRef CAS PubMed Web of Science Google Scholar
Matsumoto, R., Fujino, K., Nagata, Y., Hashiguchi, S., Ito, Y., Aihara, Y., Takahashi, Y., Maeda, K. & Sugimura, K. (2004). Allergy, 59, 533–538. Web of Science CrossRef PubMed CAS Google Scholar
Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. CrossRef CAS PubMed Web of Science Google Scholar
Nagata, Y., Fujino, K., Hashiguchi, S., Abe, N., Zaima, Y., Ito, Y., Takahashi, Y., Maeda, K. & Sugimura, K. (2000). Allergol. Int. 49, 117–124. CrossRef CAS Google Scholar
Pantoja-Uceda, D., Bruix, M., Gimenez-Gallego, G., Rico, M. & Santoro, J. (2003). Biochemistry, 42, 13839–13847. Web of Science CrossRef PubMed CAS Google Scholar
Pantoja-Uceda, D., Palomares, O., Bruix, M., Villalba, M., Rodriguez, R., Rico, M. & Santoro, J. (2004). Biochemistry, 43, 16036–16045. Web of Science CrossRef PubMed CAS Google Scholar
Park, J. W., Kang, D. B., Kim, C. W., Koh, S. H., Yum, H. Y., Kim, K. E., Hong, C. S. & Lee, K. Y. (2000). Allergy, 55, 1035–1041. Web of Science CrossRef PubMed CAS Google Scholar
Powell, H. R. (1999). Acta Cryst. D55, 1690–1695. Web of Science CrossRef CAS IUCr Journals Google Scholar
Read, R. J. & Schierbeek, A. J. (1988). J. Appl. Cryst. 21, 490–495. CrossRef CAS Web of Science IUCr Journals Google Scholar
Sali, A. & Blundell, T. L. (1993). J. Mol. Biol. 234, 779–815. CrossRef CAS PubMed Web of Science Google Scholar
Shewry, P. R., Napier, J. A. & Tatham, A. S. (1995). Plant Cell, 7, 945–956. CrossRef CAS PubMed Web of Science Google Scholar
Takahashi, Y., Ichikawa, S., Aihara, Y. & Yokota, S. (1998). Arerugi, 47, 26–33. CAS PubMed Google Scholar
Tanaka, K., Matsumoto, K., Akasawa, A., Nakajima, T., Nagasu, T., Iikura, Y. & Saito, H. (2002). Int. Arch. Allergy Immunol. 129, 49–56. Web of Science CrossRef PubMed CAS Google Scholar
Terwilliger, T. C. & Berendzen, J. (1999). Acta Cryst. D55, 849–861. Web of Science CrossRef CAS IUCr Journals Google Scholar
Wieslander, G. (1996). Allergy, 51, 661–665. CrossRef CAS PubMed Web of Science Google Scholar
Winn, M. D., Ashton, A. W., Briggs, P. J., Ballard, C. C. & Patel, P. (2002). Acta Cryst. D58, 1929–1936. Web of Science CrossRef CAS IUCr Journals Google Scholar
Yoshimasu, M. A., Zhang, J. W., Hayakawa, S. & Mine, Y. (2000). Int. Arch. Allergy Immunol. 123, 130–136. Web of Science CrossRef PubMed CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.